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Abstract 
There is growing interest in using biomarkers to predict motor recovery and outcomes after 
stroke. This review summarises progress to date, including neurophysiological and 
neuroimaging biomarkers of upper limb motor recovery and outcomes. The PREP2 algorithm 
combines clinical assessment with biomarkers in an algorithm, to predict upper limb 
functional outcomes for individual patients. To date, PREP2 is the first algorithm to be tested 
in clinical practice, and other biomarker-based algorithms are likely to follow. It is therefore 
timely to consider how such algorithms might be implemented in clinical practice. There are 
two tasks: first the prediction information needs to be obtained, and then it needs to be used; 
and the barriers and facilitators of implementation are likely to differ for these tasks. We 
identify specific elements of the Consolidated Framework for Implementation Research that 
are relevant to each of these two tasks, using the PREP2 algorithm as an example. These 
include the characteristics of the predictors and algorithm, the clinical setting and its staff, 
and the healthcare environment. Active, theoretically underpinned implementation strategies 
are needed to ensure that biomarkers are successfully used in clinical practice for predicting 
motor outcomes after stroke, and should be considered in parallel with biomarker 
development. 
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1. Introduction 
Stroke remains a leading cause of adult disability, and the global burden of stroke 
continues to grow (Feigin et al., 2015). Patient outcomes are related to initial stroke severity 
and stroke lesion volume, as well as patient age and co-morbidities; however, these factors 
are related to global outcomes, such as death and disability (Heiss & Kidwell, 2014; van 
Almenkerk, Smalbrugge, Depla, Eefsting, & Hertogh, 2013; Veerbeek, Kwakkel, van Wegen, 
Ket, & Heymans, 2011).  There is growing interest in the use of biomarkers early after stroke 
to predict subsequent recovery and outcomes for individual patients (Boyd et al., 2017; Kim 
& Winstein, 2016; Stinear, 2017). The majority of work thus far has focused on predicting 
recovery from motor impairment and motor function outcomes. There are two broad 
categories of motor system biomarkers that have received the most research attention to date: 
transcranial magnetic stimulation (TMS), and magnetic resonance imaging (MRI). This 
review will briefly describe the accumulating evidence for the use of these motor system 
biomarkers during the initial days and weeks after stroke, and then discuss the potential 
challenges and benefits of implementing these biomarkers in clinical practice. 
 
1.2 Motor system biomarkers 
Biomarkers of the functional and structural integrity of the corticomotor system can 
predict recovery from motor impairment and motor function outcomes, in individual patients. 
TMS is a safe, painless, and non-invasive technique that can be used to elicit motor evoked 
potentials (MEPs) in contralateral muscles. Patients in whom TMS can elicit MEPs (MEP+) 
in the affected upper limb within the first 7 days after stroke will experience proportional 
recovery from upper limb impairment (Byblow, Stinear, Barber, Petoe, & Ackerley, 2015; 
Stinear, Byblow, et al., 2017b) and better upper limb functional outcomes than MEP- patients 
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(Bembenek, Kurczych, Karli Nski, & Czlonkowska, 2012; Stinear, 2017). Importantly, 
patients with initially severe motor impairment can be MEP+ (Stinear, Barber, Petoe, Anwar, 
& Byblow, 2012; Stinear, Byblow, Ackerley, Barber, & Smith, 2017). Determining MEP 
status might therefore be particularly important for these patients, to distinguish between 
those with potential for good versus poor motor recovery and outcomes.  
The predictive value of lower limb MEP status has received less attention, and studies 
to date have produced conflicting results. An early study reported that MEP status predicts 
recovery from distal lower limb impairment but not independent walking (Hendricks, 
Pasman, van Limbeek, & Zwarts, 2003). Subsequent studies have reported that MEP status 
predicts the return of independent walking (Chang, Do, & Chun, 2015; Piron, Piccione, 
Tonin, & Dam, 2005), but is not superior to clinical predictors (Smith, Barber, & Stinear, 
2017), and does not predict proportional recovery from lower limb impairment (Smith, 
Byblow, Barber, & Stinear, 2017). These conflicting results may reflect that postural control 
is likely to be a greater contributor to achieving independent walking than the return of 
voluntary movement in the leg itself (Kollen et al., 2005)(Smith, Barber, & Stinear, 2017). 
Further work is needed to evaluate the usefulness of MEP status as a biomarker for lower 
limb motor recovery and outcomes after stroke. 
 Magnetic resonance imaging (MRI) can also be used to evaluate the structure and 
function of the corticomotor system. MRI has the advantage of being able to obtain measures 
from the entire sensorimotor network, in contrast to TMS which is largely confined to the 
primary motor cortex and corticospinal tract (CST). Despite this advantage, thus far the most 
robust imaging biomarkers for predicting motor recovery and outcomes after stroke are 
measures of CST integrity. The microstructural characteristics of white matter tracts, such as 
the CST, can be evaluated with diffusion-weighted imaging (Puig et al., 2017). This allows 
calculation of metrics such as fractional anisotropy within specific volumes of interest in the 
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brain and along white matter tracts such as the CST. Several studies have shown that upper 
limb recovery and outcomes are predicted by fractional anisotropy asymmetry between the 
hemispheres at key points along the CST, such as the posterior limbs of the internal capsules 
(Byblow et al., 2015; Puig et al., 2011) and the pons (Puig et al., 2013). The stroke lesion 
load calculated along the length of the CSTs can also predict subsequent upper limb motor 
recovery and outcomes (Doughty et al., 2016; Feng et al., 2015).  
Functional MRI can be used to assess the patterns and extent of cortical activity 
during passive and active upper limb movement after stroke. While there are clear 
relationships between fMRI measures and upper limb motor performance at the time of 
scanning (Buma, Lindeman, Ramsey, & Kwakkel, 2010; Favre et al., 2014; Grefkes & Ward, 
2014), few studies have identified fMRI measures that can predict motor performance at 
future time points. Two studies have identified fMRI measures that predict subsequent upper 
limb motor outcomes (Hannanu et al., 2017; Rehme et al., 2015), though these measures were 
not used to make predictions for individual patients.  While structural MRI measures of the 
CST and stroke lesion load show promise for making individualised predictions, there is 
currently no consensus regarding the use of functional MRI biomarker for predicting motor 
recovery or outcomes after stroke. 
 
1.3 Clinical usefulness of motor system biomarkers 
Motor impairment is a common symptom of stroke, and regaining motor function is 
important for the patient’s independence in daily activities (Langhorne, Coupar, & Pollock, 
2009). Being able to predict functional motor outcomes could help clinicians, patients, and 
families to set appropriate rehabilitation goals and make suitable plans for the level of support 
the patient is likely to need after discharge from hospital. However, making accurate 
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predictions for individual patients based on clinical experience or assessment alone can be 
difficult (Nijland, van Wegen, Harmeling-van der Wel, Kwakkel, 2013). This lack of 
accuracy is concerning, given that the subjective prediction of discharge destination has a 
major influence over what rehabilitation is provided and patient outcomes (Luker, Bernhardt, 
Grimmer, & Edwards, 2014). Combining clinical assessment with the biomarkers outlined 
above may enable more accurate predictions (Kim & Winstein, 2016). 
To date, only one approach has been explored for combining clinical assessment with 
biomarkers to make upper limb predictions for individual patients at the beginning of 
rehabilitation after stroke. The PREP algorithm sequentially combines assessment of paretic 
upper limb impairment with TMS and MRI within days of stroke to predict upper limb 
function at 3 months post-stroke. The PREP algorithm was developed in a group of 40 first-
ever ischaemic stroke patients (Stinear et al., 2012), and has since been refined and validated 
in an independent cohort of 192 patients, including those with haemorrhagic and previous 
stroke (Stinear, Byblow, Ackerley, Barber, et al., 2017). The PREP2 algorithm has recently 
been reported (Figure 1), which replaces the MRI biomarkers used in PREP with stroke 
severity measured with the NIHSS score (Stinear, Byblow, et al., 2017a). The PREP2 
algorithm is therefore likely to be more readily implemented in clinical practice, and is 
described below. 
Insert Figure 1 here 
The algorithm begins with an evaluation of paretic shoulder abduction and finger 
extension (SAFE), using the Medical Research Council grades. The scores for these 
movements, out of five, are summed to produce the SAFE score, out of ten. Patients who 
achieve a SAFE score of at least five within 72 hours of stroke symptom onset are most likely 
to have an excellent upper limb outcome within three months provided they are aged less 
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than 80 years (Table 1). If they are aged 80 years or more, they need to achieve a SAFE score 
of at least eight in order to have an excellent upper limb outcome; otherwise they are most 
likely to have a good upper limb outcome within three months. Patients with more severe 
initial upper limb impairment (SAFE score < 5) at 72 hours post-stroke, are assessed with 
TMS to determine the MEP status of their paretic wrist extensors. Patients who are MEP+ are 
also likely to have a good upper limb motor outcome. Patients who are MEP- are most likely 
to have a limited upper limb outcome if their NIHSS score at 72 hours post-stroke is less than 
seven; otherwise they are most likely to have a poor upper limb outcome.  
Insert Table 1 here 
Researchers who have the skills and resources to obtain MRI data from their 
participants can evaluate the stroke lesion load on the sensorimotor tracts of the ipsilesional 
hemisphere. Diffusion-weighted imaging obtained around 10 days post-stroke can be used to 
calculate the mean fractional anisotropy in volumes of interest in the posterior limbs of the 
internal capsules. Patients with a fractional anisotropy index < 0.15 are most likely to have a 
limited upper lib outcome, while those with an asymmetry index of 0.15 or more are most 
likely to have a poor upper limb outcome (Stinear, Byblow, Ackerley, Barber, et al., 2017). 
T1-weighted imaging can be combined with a template of the primary sensorimotor tracts to 
calculate the lesion load on these tracts. Patients with a lesion load less than 15% are most 
likely to have a limited upper limb outcome, while those with a lesion load of 15% or more 
are most likely to have a poor upper limb outcome (Stinear, Byblow, et al., 2017a). The 
overall accuracy of the algorithm is essentially the same when using either this MRI 
biomarker of stroke lesion load or NIHSS score for MEP- patients (Stinear, Byblow, et al., 
2017a). The sequential nature of the algorithm means that more sophisticated and expensive 
biomarkers are only obtained as required, with TMS needed for around one third of patients, 
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and the NIHSS score or MRI needed for around one sixth (Stinear, Byblow, Ackerley, 
Barber, et al., 2017; Stinear, Byblow, et al., 2017a).  
The effects on clinical practice of using biomarkers to make predictions for individual 
patients have been explored in one study thus far (Stinear, Byblow, Ackerley, Barber, et al., 
2017). This study found that using PREP algorithm predictions to guide upper limb 
rehabilitation increased therapist confidence, altered the content but not dose of upper limb 
therapy, and was associated with a reduction in length of stay by 6 days, with no detectable 
negative effects on patient outcomes (Stinear, Byblow, Ackerley, Barber, et al., 2017). These 
results indicate that using CST biomarkers to predict upper limb outcomes for individual 
patients might improve rehabilitation efficiency. However, implementation of the PREP 
algorithm, or biomarkers more generally, has not yet been attempted outside of a research 
context. Subjective predictions of discharge destination have a major influence on what 
rehabilitation is provided and patient outcomes (Luker et al., 2014), and patients and carers 
report wanting more information (Luker, Lynch, Bernhardsson, Bennett, & Bernhardt, 2015; 
Luker et al., 2017). It is therefore likely that implementation of motor system biomarkers will 
improve patient experience and outcome, but this needs to be formally evaluated.  
While there has been an exponential growth in research into biomarkers within 
medicine, little attention has been given to behaviour change of healthcare professionals in 
the development and implementation of biomarkers. There are several potential barriers and 
facilitators to implementation of biomarkers in stroke rehabilitation practice, and these are 
discussed below using the PREP2 algorithm as an example.  
 
2. Implementation of motor system biomarkers 
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There are two broad elements to consider in the implementation of biomarkers to 
predict motor outcomes for individual patients. A process for obtaining the prediction needs 
to be implemented, along with a process for communicating and using the prediction in the 
care of the patient. Here we use the Consolidated Framework for Implementation Research 
(Damschroder et al., 2009) as a guide for systematically considering potential barriers and 
facilitators for each of these processes. 
 
2.1 Obtaining the prediction 
2.1.1 Characteristics of the Predictors 
In general, prediction algorithms using biomarkers are more likely to be implemented 
if they are from a credible source, validated by high quality evidence, and clearly more 
accurate than clinical judgement. Complexity, adaptability, and cost are also important 
features. Biomarkers that require specialised technical expertise to obtain and analyse, such 
as sophisticated fMRI measures, may be too complex for widespread implementation in 
clinical practice. The complexity of the algorithm in which biomarkers are embedded may 
also create a barrier to implementation. Algorithms requiring several pieces of information 
from different sources, combined in multiple steps, are likely to be more difficult to 
implement than algorithms combining only a few pieces of information in a small number of 
steps. The PREP2 algorithm requires only the SAFE score for two-thirds of patients, and this 
simple score can be readily obtained as part of routine clinical practice.  
 Algorithms that require biomarkers to be obtained using strict protocols and on a rigid 
timeline have low adaptability, which is another potential barrier to implementation. Ideally, 
prediction algorithms will clearly identify components that require high fidelity, and those 
that can be adapted within specified parameters. For example, the PREP2 algorithm provides 
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time windows for obtaining the SAFE score and TMS measures, and the PREP algorithm 
provides a time window for obtaining MRI measures. Future research may determine if these 
time windows can be further expanded. Maximising flexibility will foster implementation 
while allowing for variations in patient availability due to factors such as their medical 
stability and time spent on other tests and treatments, as well as variations in staff availability 
due to factors such as case load, weekends and leave.  
 The cost of obtaining biomarkers is another important factor influencing their 
implementation. Biomarkers that can be obtained at low cost, using existing resources, are 
more likely to be implemented than those that require greater investment to set up and sustain 
in practice. The PREP2 algorithm begins with a low cost measure (SAFE score) and moves to 
more costly TMS only as required. The costs of purchasing the necessary equipment for TMS 
and ongoing training for staff tasked with obtaining MEP status are a potential barrier to 
implementation. Similarly, the cost of an MRI scan that might not be part of routine care, as 
well as the cost of ongoing training for staff tasked with obtaining MRI biomarkers, are 
barriers that are likely to confine these biomarkers to the realm of research rather than clinical 
care. Implementation costs might be offset by savings associated with increased rehabilitation 
efficiency and shorter length of stay. Any site considering implementing the PREP2 
algorithm would therefore need to carry out an economic analysis to determine whether 
implementation of the algorithm would be cost-effective, in addition to considering its other 
possible benefits such as helping to personalise rehabilitation for patients. 
 
2.1.2 Clinical setting 
Several features of the clinical setting’s inner environment will affect the 
implementation of motor system biomarkers. These include the available resources and 
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implementation climate. Time and money are known to be important factors in varied 
implementation theories and frameworks (Damschroder et al., 2009; Greenhalgh, Robert, 
Bate, Macfarlane, & Kyriakidou, 2005; Murray et al., 2010) and empirical studies (Huijg et 
al., 2015; Varsi, Ekstedt, Gammon, & Ruland, 2015).  
Having sufficient numbers of trained staff members who are responsible for obtaining 
algorithm information and making predictions is important for implementation. These staff 
also need ready access to the equipment and space needed to obtain biomarker information. 
The first step of the PREP2 algorithm is the SAFE score, which can be obtained in the 
patient’s bedspace with no special equipment, as part of routine clinical assessment. If 
needed, the TMS step in the algorithm requires specialised equipment that can be used in the 
patient’s bedspace. 
The implementation climate also has a powerful influence on implementation (Varsi 
et al., 2015). This includes leadership engagement, which is a key factor in successful 
implementation (Connell, McMahon, Harris, Watkins, & Eng, 2014; Damschroder & 
Lowery, 2013). Therefore to facilitate the use of prediction algorithms including biomarkers, 
it will be important to have the clinical service leaders on board, acting as opinion leaders to 
ensure the use of biomarkers is compatible with their service and seen as a relative priority. 
This includes ensuring staff have the necessary time, resources, information and feedback for 
successful implementation. For the PREP2 algorithm, this means helping staff to understand 
that using the algorithm is compatible with their values, and that those tasked with obtaining 
predictions are supported with the necessary time and resources to do so. 
 
2.1.3 Characteristics of the Health Care Professionals 
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Characteristics of the staff involved in obtaining algorithm information are also 
important.  The beliefs of healthcare staff about interventions are often more influential than 
other factors such as the strength of evidence for the intervention (Connell, McMahon, 
Tyson, Watkins, & Eng, 2016; Johanna M. Huijg et al., 2014). Biomarkers are more likely to 
be implemented in settings where staff recognise the value of accurate prediction 
information, and the limitations of predictions made on clinical assessment alone. The desire 
to improve prediction accuracy and rehabilitation efficiency is compatible with implementing 
biomarkers in clinical practice. Staff will also need to have the right skills to undertake the 
assessments required and feel confident in their abilities. Therefore some training is likely to 
be required. Implementation depends on identifying staff members who will be responsible 
for obtaining algorithm and biomarker information. It is not clear exactly whose role 
obtaining the measures should be, and it is likely to require a multi-disciplinary approach, 
with different members obtaining different measures, adding to the complexity. The SAFE 
score can be readily obtained by physical and occupational therapists, and could become part 
of current routine practice. Consistency in muscle testing technique and recording of the 
SAFE score on appropriate days by the whole team will need to be actively implemented in 
order to use PREP2 in clinical practice. In contrast, the TMS biomarker requires a different 
skillset, and will need to be obtained by specifically trained members of the team. Obtaining 
MRI biomarkers is likely to remain the responsibility of researchers who have the specialised 
skills required. 
 
2.2 Communicating and using the prediction 
Once a prediction has been obtained for an individual patient, this information needs 
to be communicated and used in order to be of value. Knowledge alone is unlikely to change 
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behaviour. Several factors are likely to affect the implementation of using prediction 
information. 
 
2.2.1 Characteristics of the Prediction 
Predictions that are relatively simple and easily understood by all parties will be more 
readily communicated and used in clinical practice. Some studies simply dichotomise the 
predicted outcome (Nijland, van Wegen, Harmeling-van der Wel, Kwakkel, 2010; Persson, 
Alt Murphy, Danielsson, Lundgren-Nilsson, & Sunnerhagen, 2015), which is easily 
understood but not very precise. Other studies have used multivariable linear regression 
analyses and produced mathematical equations combining several variables to predict the 
patient’s score on a clinical assessment scale. The patient’s numerical score might be 
predicted with reasonable precision, but not give a clear picture of the level of function the 
patient can expect to achieve in their daily activities. The PREP2 algorithm makes one of four 
predictions of upper limb functional outcome, which are easily understood in terms of what 
the patient will probably be able to do in their daily life (Table 1) (Stinear, Byblow, et al., 
2017a). These features of the predictions facilitate their implementation.  
The successful implementation of communicating and using prediction information 
also depends on how the information is presented. The written and verbal information 
provided to the clinical team, patient and their family need to be simple, clear, and consistent. 
Prediction information also needs to be integrated with the patient’s clinical records, which 
may be in paper-based or electronic systems, or a combination of both. The compatibility of 
the prediction information with existing systems will affect its accessibility and usefulness to 
the rehabilitation team. The PREP2 algorithm has several resources for communicating 
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prediction information, including written information for the patient’s rehabilitation team and 
for the patient and their family. 
The trialability of new processes also affects their implementation. A process that can 
be tested and then stopped if necessary is more likely to be implemented than one that 
requires ongoing use once initiated. Obtaining, communicating and using prediction 
information does not replace an existing process, and can therefore be stopped at any time 
without having to revert to previous practices. The relatively high trialability of 
communicating and using motor predictions therefore facilitates their implementation. 
 
2.2.2 Clinical setting 
 Characteristics of the clinical setting will also affect how readily predictions will be 
communicated and used. The clinical setting can support implementation by ensuring staff 
are provided with resources and training, as well as opportunities for practice and feedback. 
Training in the communication of predictions will need to be provided to all team members, 
including medical and nursing staff, in addition to allied health staff. Training will also need 
to be provided on an ongoing basis, as staff typically rotate through services, and new staff 
join the rehabilitation on a regular basis. A positive learning climate, where staff feel safe to 
try new things despite a risk of failure, will also support staff as they learn to communicate 
and use predictions. Clear lines of communication are needed to ensure that predictions are 
shared within the clinical team, and handed over to other clinical teams caring for the patient. 
A qualitative systematic review found that patients want information to help them understand 
stroke recovery, but highlighted the need for consistency of information across the multi-
disciplinary team (Luker et al., 2015). Therefore processes will need to be worked out in each 
clinical settings to ensure consistent communication of predictions. 
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2.2.3 Characteristics of the Health Care Professionals 
Identifying which staff members are responsible for communicating predictions to the 
rest of the clinical team, and to the patient and their family, is essential. These staff members 
need specific training and support so they are well-equipped to effectively, confidently and 
accurately convey predictions. Unfamiliarity with providing individualised prognostic 
information is a major barrier for therapists considering using this type of information. Other 
healthcare professionals, specifically physicians, have a great deal more training and 
experience, particularly in areas such as oncology. For allied health professionals working in 
rehabilitation, giving individualised predictions is new territory. Therapists involved in this 
process may find negative predictions particularly challenging. Therapists tend to see 
themselves as allies and advocates for their patients, and providing a negative prediction may 
seem incompatible with their role. Their fears that negative predictions might demotivate the 
patient and be used to ration therapy need to be addressed as part of the implementation 
process. Concerns about the accuracy of predictions also need to be addressed. Therapists’ 
confidence in their ability to have potentially difficult conversations with their patient is 
likely to affect whether and how they communicate and use prediction information. Hence 
implementation strategies will be needed to support therapists and overcome these barriers. 
 
2.3 Outer Setting 
Implementation of biomarkers will not occur in isolation, the wider context needs to 
be considered. As yet, there is no external policy or incentives that include biomarkers, as 
evidence is still preliminary. However, with stroke rehabilitation, clinical guidelines and 
registries have been key drivers in advancing care (Cadilhac et al., 2016; Royal College of 
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Physicians Intercollegiate Stroke Working Party, 2016). Therefore it will be interesting to see 
what the external drive for biomarkers in stroke rehabilitation will be. The patients’ needs 
and push for this type of information is also likely to evolve as predictor information 
becomes more commonplace. Their expectations and requirements, as well as their tolerance 
to the measures needed to obtain prediction information, will also influence implementation. 
 
3. Conclusion 
The potential benefit of applying implementation research is that it can reduce the 
often cited 17-year time lag between scientific evidence reporting and clinical 
implementation (Morris, Wooding, & Grant, 2011). The basic science of developing and 
combining robust biomarkers of motor recovery has now reached an exciting stage, where 
these biomarkers can start to be integrated into clinical practice and improve patient care. 
This review has used the CFIR to systematically explore the domains likely to influence 
implementation of biomarkers in stroke rehabilitation. Using the CFIR prior to 
implementation has allowed groups to identify potential barriers and utilise this information 
to refine and adapt both their implementation strategy and the innovation before 
implementation began (Kirk et al., 2016). In stroke rehabilitation, an effective clinical 
protocol was successfully up-scaled by developing an implementation strategy alongside the 
original clinical trial (Middleton et al., 2016).  The cluster-randomised controlled trial 
‘Quality in Acute Stroke Care’ (QASC)’ cluster-randomised controlled trial by Middleton et 
al (2011).and colleagues demonstrated an evidence-based protocol to improve management 
of fever, hyperglycaemia, and swallowing dysfunction in acute stroke units. The protocol 
reduced mortality and patient dependency. A prospective pre-test/post-test study of a 
corresponding implementation strategy resulted in successful upscale of the intervention 
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tobeing used inup-scaled across New South Wales (Middleton et al, 2016)., Given the 
complex nature of the processes required for biomarkers to become part of routine practice, 
implementation research to explore these factors is warranted. This should be considered in 
parallel with further biomarker development. The QASC study is an example in stroke 
rehabilitation care where an intervention was developed, evaluated, then implemented using a 
concurrently and theoretically underpinned implementation strategy (Dale et al., 2015; 
Middleton et al., 2016; Middleton et al., 2011). This is a modeln example that could be 
followed, and demonstrates a real-life example of the all the stages of the MRC framework 
for the development and evaluation of complex interventions through to the implementation 
stage (Craig et al., 2008). Given the complex nature of the processes required for biomarkers 
to become part of routine practice, further research into implementation research to explore 
these factors is warranted and . This should be considered in parallel with further biomarker 
development. 
The implementation processes for obtaining prediction information, and then 
communicating and using this information, will differ between sites depending on the 
characteristics of the clinical setting and people involved, as outlined above. In general, 
implementation is likely to involve an initial phase of adopting the new processes and then 
adapting them to suit the local setting. Engaged leadership at multiple levels of the 
organisation, appropriate resourcing, and active dissemination of information will be needed. 
While there are some prognostic tools (like the PREP algorithm) that have been validated, 
they don’t yet have an explicit implementation strategy alongside them that addresses these 
issues – and this is where the work needs to be done.  
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Table 1: Algorithm predictions 
 
Predicted 
outcome 
Description Rehabilitation focus 
Excellent Potential to make a complete, or near-
complete, recovery of hand and arm 
function within three months 
Promote normal use of the 
affected hand and arm with task-
specific practice, while 
minimising adaptation and 
compensation. 
Good Potential to be using the affected hand 
and arm for most activities of daily 
living within three months, though with 
some weakness, slowness, or 
clumsiness 
Promote normal function of the 
affected hand and arm by 
improving strength, 
coordination, and fine motor 
control with repetitive and task-
specific practice. Minimise 
compensation with the other 
hand and arm, and the trunk. 
Limited Potential to regain movement in the 
affected hand and arm within three 
months, but daily activities are likely to 
require significant modification 
Promote movement and reduce 
impairment by improving 
strength and active range of 
motion. Promote adaptation in 
daily activities, incorporating the 
affected upper limb wherever 
safely possible. 
Poor Unlikely to regain useful movement of 
the hand and arm within three months 
Prevent secondary complications 
such as pain, spasticity and 
shoulder instability. Reduce 
disability by learning to 
complete daily activities with the 
stronger hand and arm. 
  
28 
 
Figure caption 
Figure 1: The PREP2 algorithm predicts upper limb functional outcome at 3 months post-
stroke. The four possible upper limb outcomes are colour-coded. The coloured dots depict the 
proportion of patients expected to achieve each colour-coded outcome, depending on their 
pathway through the algorithm, based on the results of the CART analysis. Patients who 
achieve a SAFE score of five or more within 72 hours of stroke symptom onset, and are less 
than 80 years old, are most likely to have an Excellent upper limb outcome. Patients who 
achieve a SAFE score of five or more within 72 hours of stroke symptom onset and are 80 
years old or more, are most likely to have an Excellent upper limb outcome provided their 
SAFE score is at least 8; otherwise they are likely to have a Good upper limb outcome. 
Patients whose SAFE score is less than five at 72 hours after stroke symptom onset need 
TMS to determine MEP status in the paretic upper limb, a key biomarker of corticospinal 
tract integrity. If a MEP can be elicited (MEP+) approximately 5 days post-stroke then the 
patient is likely to have at least a Good upper limb outcome. If a MEP cannot be elicited, the 
NIHSS score obtained 3 days post-stroke can be used to predict either a Limited outcome if 
the score is less than seven, or a Poor outcome if the score is seven or more. 
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